Related Experiment Video
Updated: Jul 25, 2026
11:00
High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
Published on: November 28, 2016
12.0K
Nanopore-Based Metagenomic Sequencing in Respiratory Tract Infection: A Developing Diagnostic Platform
Robert Chapman1, Luke Jones2, Alberto D'Angelo2
1Princess Alexandra Hospital, Hamstel Road, Harlow, CM20 1QX, UK. robert.chapman2@nhs.net.
Lung
|April 3, 2023
Summary
Nanopore sequencing (NPS) offers faster pathogen identification for respiratory tract infections (RTIs) than traditional methods. This rapid diagnosis improves antimicrobial stewardship and clinical outcomes, making NPS a promising tool for RTI management.
Area of Science:
- Clinical microbiology
- Infectious diseases
- Genomic technologies
Background:
- Respiratory tract infections (RTIs) are a major global health concern, leading to significant morbidity and mortality.
- Current diagnostic methods, primarily culture-based, are slow, often delaying targeted antimicrobial therapy and prolonging broad-spectrum use.
- Inefficient pathogen identification in RTIs impacts antimicrobial stewardship and patient outcomes.
Purpose of the Study:
- To review Nanopore sequencing (NPS) as a diagnostic tool for respiratory tract infections (RTIs).
- To discuss the advantages and limitations of NPS in the context of RTI diagnostics.
- To explore the future implementation of NPS platforms in clinical settings for RTI management.
Main Methods:
- Review of existing literature on Nanopore sequencing (NPS) applications in respiratory tract infection (RTI) diagnostics.
- Comparative analysis of NPS against traditional culture-based methods for pathogen identification and antimicrobial resistance profiling.
- Discussion of technological advancements, accessibility, and infrastructure requirements for NPS platforms.
Main Results:
- Nanopore sequencing (NPS) demonstrates potential for rapid and efficient identification of pathogens and antimicrobial resistance profiles in respiratory samples.
- NPS offers a significant speed advantage over conventional sputum culture methods.
- The technology is becoming more accessible, with some platforms requiring minimal sample preparation and laboratory infrastructure.
Conclusions:
- Nanopore sequencing (NPS) presents a promising advancement for the rapid diagnosis of respiratory tract infections (RTIs).
- Faster pathogen identification via NPS can enhance antimicrobial stewardship and improve clinical outcomes.
- Further research is needed to address clinical utility and optimal implementation strategies for NPS in RTI diagnostic pathways.
Related Concept Videos
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...